Charles Schwab Investment Management Inc Gossamer Bio, Inc. Transaction History
Charles Schwab Investment Management Inc
- $557 Billion
- Q2 2025
A detailed history of Charles Schwab Investment Management Inc transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 1,621,419 shares of GOSS stock, worth $3.68 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,621,419
Previous 1,138,947
42.36%
Holding current value
$3.68 Million
Previous $1.25 Million
59.27%
% of portfolio
0.0%
Previous 0.0%
Shares
27 transactions
Others Institutions Holding GOSS
# of Institutions
144Shares Held
159MCall Options Held
2.89MPut Options Held
130K-
Octagon Capital Advisors LP New York, NY18.4MShares$41.7 Million8.57% of portfolio
-
Nea Management Company, LLC Timonium, MD18.1MShares$41.1 Million1.84% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.4MShares$25.9 Million0.0% of portfolio
-
Arch Venture Management, LLC Chicago, IL8.06MShares$18.3 Million5.25% of portfolio
-
Acadian Asset Management LLC Boston, MA7.15MShares$16.2 Million0.02% of portfolio
About Gossamer Bio, Inc.
- Ticker GOSS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,954,000
- Market Cap $213M
- Description
- Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...